|
Pfizer to Acquire King Pharmaceuticals, Inc.
|
13 October 2010 |
|
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
|
28 September 2010 |
|
Pfizer Commended For Leadership In Addressing Climate Change
|
22 September 2010 |
|
Pfizer to Acquire FoldRx Pharmaceuticals
|
02 September 2010 |
|
World Health Organization Grants Prequalification to Prevenar 13
|
24 August 2010 |
|
Pfizer Reports Second-Quarter 2010 Results
|
11 August 2010 |
|
Pfizer to Offer Free Public Access to Mental Health Assessment Tools
|
23 July 2010 |
|
Pfizer Strengthens Manufacturing Capabilities in Asia
|
13 July 2010 |
|
Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program
|
25 June 2010 |
|
Phase 3 Study Showed MACUGEN® Improved Vision Over Standard of Care
|
07 June 2010 |
|
Pfizer Global Manufacturing Announces Plans to Reconfigure its Global Plant Network
|
20 May 2010 |
|
World Bank and Pfizer Announce Initiative to Help Improve Healthcare Delivery
|
26 April 2010 |
|
Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma
|
23 April 2010 |
|
Stemgent and Pfizer Announce Collaboration
|
16 April 2010 |
|
Pfizer Posts Details About Interactions With U.S. Physicians
|
01 April 2010 |
|
Pfizer Signs Long-Term Agreement to Supply Prevenar 13 to The World's Poorest Countries
|
24 March 2010 |
|
Pfizer Discontinues A Phase 3 Study Of Figitumumab
|
12 March 2010 |
|
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon
|
04 March 2010 |
|
Pfizer's Prevnar 13 Recommended by CDC's Advisory Committee On Immunization Practices
|
25 February 2010 |
|
Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
|
24 February 2010 |